 | • レポートコード：GIR-107A14347 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アクチビンI型受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アクチビンI型受容体の種類別市場規模（LJPC-6417、TP-0184、ジピリダモール、その他）、用途別市場規模（アルポート症候群、慢性腎臓病、腎線維化、肥満、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アクチビンI型受容体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Blueprint Medicines Corp、Daiichi Sankyo Company Ltd、La Jolla Pharmaceutical Company、Oncodesign SA、Tolero Pharmaceuticals Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：LJPC-6417、TP-0184、ジピリダモール、その他 ・用途別分析2016年-2026年：アルポート症候群、慢性腎臓病、腎線維化、肥満、その他 ・アクチビンI型受容体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アクチビンI型受容体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アクチビンI型受容体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アクチビンI型受容体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アクチビンI型受容体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Activin Receptor Type 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Activin Receptor Type 1 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Activin Receptor Type 1 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Activin Receptor Type 1 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
LJPC-6417
TP-0184
Dipyridamole
Others
Market segment by Application can be divided into
Alport Syndrome
Chronic Kidney Disease
Kidney Fibrosis
Obesity
Others
The key market players for global Activin Receptor Type 1 market are listed below:
Blueprint Medicines Corp
Daiichi Sankyo Company Ltd
La Jolla Pharmaceutical Company
Oncodesign SA
Tolero Pharmaceuticals Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Activin Receptor Type 1 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Activin Receptor Type 1, with price, sales, revenue and global market share of Activin Receptor Type 1 from 2019 to 2021.
Chapter 3, the Activin Receptor Type 1 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Activin Receptor Type 1 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Activin Receptor Type 1 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Activin Receptor Type 1 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Activin Receptor Type 1 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Activin Receptor Type 1 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 LJPC-6417
1.2.3 TP-0184
1.2.4 Dipyridamole
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Activin Receptor Type 1 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Alport Syndrome
1.3.3 Chronic Kidney Disease
1.3.4 Kidney Fibrosis
1.3.5 Obesity
1.3.6 Others
1.4 Global Activin Receptor Type 1 Market Size & Forecast
1.4.1 Global Activin Receptor Type 1 Sales in Value (2016-2026))
1.4.2 Global Activin Receptor Type 1 Sales in Volume (2016-2026)
1.4.3 Global Activin Receptor Type 1 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Activin Receptor Type 1 Production Capacity Analysis
1.5.1 Global Activin Receptor Type 1 Total Production Capacity (2016-2026)
1.5.2 Global Activin Receptor Type 1 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Activin Receptor Type 1 Market Drivers
1.6.2 Activin Receptor Type 1 Market Restraints
1.6.3 Activin Receptor Type 1 Trends Analysis
2 Manufacturers Profiles
2.1 Blueprint Medicines Corp
2.1.1 Blueprint Medicines Corp Details
2.1.2 Blueprint Medicines Corp Major Business
2.1.3 Blueprint Medicines Corp Activin Receptor Type 1 Product and Services
2.1.4 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Daiichi Sankyo Company Ltd
2.2.1 Daiichi Sankyo Company Ltd Details
2.2.2 Daiichi Sankyo Company Ltd Major Business
2.2.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product and Services
2.2.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 La Jolla Pharmaceutical Company
2.3.1 La Jolla Pharmaceutical Company Details
2.3.2 La Jolla Pharmaceutical Company Major Business
2.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product and Services
2.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Oncodesign SA
2.4.1 Oncodesign SA Details
2.4.2 Oncodesign SA Major Business
2.4.3 Oncodesign SA Activin Receptor Type 1 Product and Services
2.4.4 Oncodesign SA Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Tolero Pharmaceuticals Inc
2.5.1 Tolero Pharmaceuticals Inc Details
2.5.2 Tolero Pharmaceuticals Inc Major Business
2.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product and Services
2.5.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Activin Receptor Type 1 Sales by Manufacturer
3.1 Global Activin Receptor Type 1 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Activin Receptor Type 1 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Activin Receptor Type 1
3.4 Market Concentration Rate
3.4.1 Top 3 Activin Receptor Type 1 Manufacturer Market Share
3.4.2 Top 6 Activin Receptor Type 1 Manufacturer Market Share
3.5 Global Activin Receptor Type 1 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Activin Receptor Type 1 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Activin Receptor Type 1 Market Size by Region
4.1.1 Global Activin Receptor Type 1 Sales in Volume by Region (2016-2026)
4.1.2 Global Activin Receptor Type 1 Revenue by Region (2016-2026)
4.2 North America Activin Receptor Type 1 Revenue (2016-2026)
4.3 Europe Activin Receptor Type 1 Revenue (2016-2026)
4.4 Asia-Pacific Activin Receptor Type 1 Revenue (2016-2026)
4.5 South America Activin Receptor Type 1 Revenue (2016-2026)
4.6 Middle East and Africa Activin Receptor Type 1 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Activin Receptor Type 1 Sales in Volume by Type (2016-2026)
5.2 Global Activin Receptor Type 1 Revenue by Type (2016-2026)
5.3 Global Activin Receptor Type 1 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Activin Receptor Type 1 Sales in Volume by Application (2016-2026)
6.2 Global Activin Receptor Type 1 Revenue by Application (2016-2026)
6.3 Global Activin Receptor Type 1 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Activin Receptor Type 1 Sales by Type (2016-2026)
7.2 North America Activin Receptor Type 1 Sales by Application (2016-2026)
7.3 North America Activin Receptor Type 1 Market Size by Country
7.3.1 North America Activin Receptor Type 1 Sales in Volume by Country (2016-2026)
7.3.2 North America Activin Receptor Type 1 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Activin Receptor Type 1 Sales by Type (2016-2026)
8.2 Europe Activin Receptor Type 1 Sales by Application (2016-2026)
8.3 Europe Activin Receptor Type 1 Market Size by Country
8.3.1 Europe Activin Receptor Type 1 Sales in Volume by Country (2016-2026)
8.3.2 Europe Activin Receptor Type 1 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Activin Receptor Type 1 Sales by Type (2016-2026)
9.2 Asia-Pacific Activin Receptor Type 1 Sales by Application (2016-2026)
9.3 Asia-Pacific Activin Receptor Type 1 Market Size by Region
9.3.1 Asia-Pacific Activin Receptor Type 1 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Activin Receptor Type 1 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Activin Receptor Type 1 Sales by Type (2016-2026)
10.2 South America Activin Receptor Type 1 Sales by Application (2016-2026)
10.3 South America Activin Receptor Type 1 Market Size by Country
10.3.1 South America Activin Receptor Type 1 Sales in Volume by Country (2016-2026)
10.3.2 South America Activin Receptor Type 1 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Activin Receptor Type 1 Sales by Type (2016-2026)
11.2 Middle East & Africa Activin Receptor Type 1 Sales by Application (2016-2026)
11.3 Middle East & Africa Activin Receptor Type 1 Market Size by Country
11.3.1 Middle East & Africa Activin Receptor Type 1 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Activin Receptor Type 1 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Activin Receptor Type 1 Typical Distributors
12.3 Activin Receptor Type 1 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Activin Receptor Type 1 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Activin Receptor Type 1 Revenue by Application, (USD Million), 2021-2026
Table 3. Blueprint Medicines Corp Basic Information, Manufacturing Base and Competitors
Table 4. Blueprint Medicines Corp Major Business
Table 5. Blueprint Medicines Corp Activin Receptor Type 1 Product and Services
Table 6. Blueprint Medicines Corp Activin Receptor Type 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Company Ltd Major Business
Table 9. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product and Services
Table 10. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 12. La Jolla Pharmaceutical Company Major Business
Table 13. La Jolla Pharmaceutical Company Activin Receptor Type 1 Product and Services
Table 14. La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Oncodesign SA Basic Information, Manufacturing Base and Competitors
Table 16. Oncodesign SA Major Business
Table 17. Oncodesign SA Activin Receptor Type 1 Product and Services
Table 18. Oncodesign SA Activin Receptor Type 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Tolero Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Tolero Pharmaceuticals Inc Major Business
Table 21. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product and Services
Table 22. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Activin Receptor Type 1 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 24. Global Activin Receptor Type 1 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Activin Receptor Type 1, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Activin Receptor Type 1 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 27. Head Office and Activin Receptor Type 1 Production Site of Key Manufacturer
Table 28. Activin Receptor Type 1 New Entrant and Capacity Expansion Plans
Table 29. Activin Receptor Type 1 Mergers & Acquisitions in the Past Five Years
Table 30. Global Activin Receptor Type 1 Sales by Region (2016-2021e) & (K Pcs)
Table 31. Global Activin Receptor Type 1 Sales by Region (2021-2026) & (K Pcs)
Table 32. Global Activin Receptor Type 1 Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Activin Receptor Type 1 Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Activin Receptor Type 1 Sales by Type (2016-2021e) & (K Pcs)
Table 35. Global Activin Receptor Type 1 Sales by Type (2021-2026) & (K Pcs)
Table 36. Global Activin Receptor Type 1 Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Activin Receptor Type 1 Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Activin Receptor Type 1 Price by Type (2016-2021e) & (USD/Pcs)
Table 39. Global Activin Receptor Type 1 Price by Type (2021-2026) & (USD/Pcs)
Table 40. Global Activin Receptor Type 1 Sales by Application (2016-2021e) & (K Pcs)
Table 41. Global Activin Receptor Type 1 Sales by Application (2021-2026) & (K Pcs)
Table 42. Global Activin Receptor Type 1 Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Activin Receptor Type 1 Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Activin Receptor Type 1 Price by Application (2016-2021e) & (USD/Pcs)
Table 45. Global Activin Receptor Type 1 Price by Application (2021-2026) & (USD/Pcs)
Table 46. North America Activin Receptor Type 1 Sales by Country (2016-2021e) & (K Pcs)
Table 47. North America Activin Receptor Type 1 Sales by Country (2021-2026) & (K Pcs)
Table 48. North America Activin Receptor Type 1 Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Activin Receptor Type 1 Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Activin Receptor Type 1 Sales by Type (2016-2021e) & (K Pcs)
Table 51. North America Activin Receptor Type 1 Sales by Type (2021-2026) & (K Pcs)
Table 52. North America Activin Receptor Type 1 Sales by Application (2016-2021e) & (K Pcs)
Table 53. North America Activin Receptor Type 1 Sales by Application (2021-2026) & (K Pcs)
Table 54. Europe Activin Receptor Type 1 Sales by Country (2016-2021e) & (K Pcs)
Table 55. Europe Activin Receptor Type 1 Sales by Country (2021-2026) & (K Pcs)
Table 56. Europe Activin Receptor Type 1 Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Activin Receptor Type 1 Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Activin Receptor Type 1 Sales by Type (2016-2021e) & (K Pcs)
Table 59. Europe Activin Receptor Type 1 Sales by Type (2021-2026) & (K Pcs)
Table 60. Europe Activin Receptor Type 1 Sales by Application (2016-2021e) & (K Pcs)
Table 61. Europe Activin Receptor Type 1 Sales by Application (2021-2026) & (K Pcs)
Table 62. Asia-Pacific Activin Receptor Type 1 Sales by Region (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific Activin Receptor Type 1 Sales by Region (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Activin Receptor Type 1 Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Activin Receptor Type 1 Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Activin Receptor Type 1 Sales by Type (2016-2021e) & (K Pcs)
Table 67. Asia-Pacific Activin Receptor Type 1 Sales by Type (2021-2026) & (K Pcs)
Table 68. Asia-Pacific Activin Receptor Type 1 Sales by Application (2016-2021e) & (K Pcs)
Table 69. Asia-Pacific Activin Receptor Type 1 Sales by Application (2021-2026) & (K Pcs)
Table 70. South America Activin Receptor Type 1 Sales by Country (2016-2021e) & (K Pcs)
Table 71. South America Activin Receptor Type 1 Sales by Country (2021-2026) & (K Pcs)
Table 72. South America Activin Receptor Type 1 Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Activin Receptor Type 1 Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Activin Receptor Type 1 Sales by Type (2016-2021e) & (K Pcs)
Table 75. South America Activin Receptor Type 1 Sales by Type (2021-2026) & (K Pcs)
Table 76. South America Activin Receptor Type 1 Sales by Application (2016-2021e) & (K Pcs)
Table 77. South America Activin Receptor Type 1 Sales by Application (2021-2026) & (K Pcs)
Table 78. Middle East & Africa Activin Receptor Type 1 Sales by Country (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa Activin Receptor Type 1 Sales by Country (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Activin Receptor Type 1 Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Activin Receptor Type 1 Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Activin Receptor Type 1 Sales by Type (2016-2021e) & (K Pcs)
Table 83. Middle East & Africa Activin Receptor Type 1 Sales by Type (2021-2026) & (K Pcs)
Table 84. Middle East & Africa Activin Receptor Type 1 Sales by Application (2016-2021e) & (K Pcs)
Table 85. Middle East & Africa Activin Receptor Type 1 Sales by Application (2021-2026) & (K Pcs)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Activin Receptor Type 1 Typical Distributors
Table 89. Activin Receptor Type 1 Typical Customers
List of Figures
Figure 1. Activin Receptor Type 1 Picture
Figure 2. Global Activin Receptor Type 1 Sales Market Share by Type in 2020
Figure 3. LJPC-6417
Figure 4. TP-0184
Figure 5. Dipyridamole
Figure 6. Others
Figure 7. Global Activin Receptor Type 1 Sales Market Share by Application in 2020
Figure 8. Alport Syndrome
Figure 9. Chronic Kidney Disease
Figure 10. Kidney Fibrosis
Figure 11. Obesity
Figure 12. Others
Figure 13. Global Activin Receptor Type 1 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Activin Receptor Type 1 Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Activin Receptor Type 1 Sales (2016-2026) & (K Pcs)
Figure 16. Global Activin Receptor Type 1 Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Activin Receptor Type 1 Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Activin Receptor Type 1 Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Activin Receptor Type 1 Market Drivers
Figure 20. Activin Receptor Type 1 Market Restraints
Figure 21. Activin Receptor Type 1 Market Trends
Figure 22. Global Activin Receptor Type 1 Sales Market Share by Manufacturer in 2020
Figure 23. Global Activin Receptor Type 1 Revenue Market Share by Manufacturer in 2020
Figure 24. Activin Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Activin Receptor Type 1 Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Activin Receptor Type 1 Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Activin Receptor Type 1 Sales Market Share by Region (2016-2026)
Figure 28. Global Activin Receptor Type 1 Revenue Market Share by Region (2016-2026)
Figure 29. North America Activin Receptor Type 1 Revenue (2016-2026) & (USD Million)
Figure 30. Europe Activin Receptor Type 1 Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Activin Receptor Type 1 Revenue (2016-2026) & (USD Million)
Figure 32. South America Activin Receptor Type 1 Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Activin Receptor Type 1 Revenue (2016-2026) & (USD Million)
Figure 34. Global Activin Receptor Type 1 Sales Market Share by Type (2016-2026)
Figure 35. Global Activin Receptor Type 1 Revenue Market Share by Type (2016-2026)
Figure 36. Global Activin Receptor Type 1 Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Activin Receptor Type 1 Sales Market Share by Application (2016-2026)
Figure 38. Global Activin Receptor Type 1 Revenue Market Share by Application (2016-2026)
Figure 39. Global Activin Receptor Type 1 Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Activin Receptor Type 1 Sales Market Share by Type (2016-2026)
Figure 41. North America Activin Receptor Type 1 Sales Market Share by Application (2016-2026)
Figure 42. North America Activin Receptor Type 1 Sales Market Share by Country (2016-2026)
Figure 43. North America Activin Receptor Type 1 Revenue Market Share by Country (2016-2026)
Figure 44. United States Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Activin Receptor Type 1 Sales Market Share by Type (2016-2026)
Figure 48. Europe Activin Receptor Type 1 Sales Market Share by Application (2016-2026)
Figure 49. Europe Activin Receptor Type 1 Sales Market Share by Country (2016-2026)
Figure 50. Europe Activin Receptor Type 1 Revenue Market Share by Country (2016-2026)
Figure 51. Germany Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Activin Receptor Type 1 Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Activin Receptor Type 1 Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Activin Receptor Type 1 Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Activin Receptor Type 1 Revenue Market Share by Region (2016-2026)
Figure 60. China Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Activin Receptor Type 1 Sales Market Share by Type (2016-2026)
Figure 67. South America Activin Receptor Type 1 Sales Market Share by Application (2016-2026)
Figure 68. South America Activin Receptor Type 1 Sales Market Share by Country (2016-2026)
Figure 69. South America Activin Receptor Type 1 Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Activin Receptor Type 1 Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Activin Receptor Type 1 Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Activin Receptor Type 1 Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Activin Receptor Type 1 Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Activin Receptor Type 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のアクチビン市場 2021：企業別、地域別、種類・用途別 The Activin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent dev…- 世界のアクチビン＆インヒビン市場 2021：企業別、地域別、種類・用途別 The Activin and Inhibin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のアンジオテンシンII受容体拮抗薬市場 2021：企業別、地域別、種類・用途別 The Angiotensin II Receptor Blockers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のGタンパク質結合胆汁酸受容体1（GPBAR1）市場 2021：企業別、地域別、種類・用途別 The G Protein Coupled Bile Acid Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のメラニン凝集ホルモン受容体1市場 2021：企業別、地域別、種類・用途別 The Melanin Concentrating Hormone Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…